These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
761 related articles for article (PubMed ID: 34840971)
21. Prediction and analysis of hub genes between glioblastoma and low-grade glioma using bioinformatics analysis. Xu B Medicine (Baltimore); 2021 Jan; 100(3):e23513. PubMed ID: 33545929 [TBL] [Abstract][Full Text] [Related]
22. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer. Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036 [TBL] [Abstract][Full Text] [Related]
23. Bioinformatics analysis of potential core genes for glioblastoma. Zhang Y; Yang X; Zhu XL; Hao JQ; Bai H; Xiao YC; Wang ZZ; Hao CY; Duan HB Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32667033 [TBL] [Abstract][Full Text] [Related]
24. Integrated Analysis of Hub Genes and Pathways In Esophageal Carcinoma Based on NCBI's Gene Expression Omnibus (GEO) Database: A Bioinformatics Analysis. Yu-Jing T; Wen-Jing T; Biao T Med Sci Monit; 2020 Aug; 26():e923934. PubMed ID: 32756534 [TBL] [Abstract][Full Text] [Related]
25. Identification of Potential Biomarkers Associated with Prognosis in Gastric Cancer via Bioinformatics Analysis. Li D; Yin Y; He M; Wang J Med Sci Monit; 2021 Feb; 27():e929104. PubMed ID: 33582701 [TBL] [Abstract][Full Text] [Related]
26. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma. Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538 [TBL] [Abstract][Full Text] [Related]
27. FN1, SPARC, and SERPINE1 are highly expressed and significantly related to a poor prognosis of gastric adenocarcinoma revealed by microarray and bioinformatics. Li L; Zhu Z; Zhao Y; Zhang Q; Wu X; Miao B; Cao J; Fei S Sci Rep; 2019 May; 9(1):7827. PubMed ID: 31127138 [TBL] [Abstract][Full Text] [Related]
28. SOX9 and IL1A as the Potential Gene Biomarkers of the Oral Cancer. Li T; Cheng D; Guo J; Chen H; Zhang S; Bao Y Comb Chem High Throughput Screen; 2023; 26(8):1461-1479. PubMed ID: 35762542 [TBL] [Abstract][Full Text] [Related]
29. Prognostic Markers Identification in Glioma by Gene Expression Profile Analysis. Hu G; Wang R; Wei B; Wang L; Yang Q; Kong D; Du C J Comput Biol; 2020 Jan; 27(1):81-90. PubMed ID: 31433208 [TBL] [Abstract][Full Text] [Related]
30. Identification and Integrate Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer Based on Bioinformatics Analysis. Gong K; Zhou H; Liu H; Xie T; Luo Y; Guo H; Chen J; Tan Z; Yang Y; Xie L Technol Cancer Res Treat; 2021; 20():15330338211060202. PubMed ID: 34825846 [No Abstract] [Full Text] [Related]
31. Screening and Identification of Key Biomarkers in Inflammatory Breast Cancer Through Integrated Bioinformatic Analyses. Wu J; Lv Q; Huang H; Zhu M; Meng D Genet Test Mol Biomarkers; 2020 Aug; 24(8):484-491. PubMed ID: 32598242 [No Abstract] [Full Text] [Related]
32. Identification of potential crucial genes and molecular mechanisms in glioblastoma multiforme by bioinformatics analysis. Chen X; Pan Y; Yan M; Bao G; Sun X Mol Med Rep; 2020 Aug; 22(2):859-869. PubMed ID: 32467990 [TBL] [Abstract][Full Text] [Related]
33. Identification of core genes and outcomes in hepatocellular carcinoma by bioinformatics analysis. Shen S; Kong J; Qiu Y; Yang X; Wang W; Yan L J Cell Biochem; 2019 Jun; 120(6):10069-10081. PubMed ID: 30525236 [TBL] [Abstract][Full Text] [Related]
34. TCGA Database-Based Screening of Tumor Microenvironment Immunomodulators Related to Bladder Cancer Prognosis. Ye JN; Gan MP; Wu XL; Dong Z; Mai HH Ann Clin Lab Sci; 2024 May; 54(3):299-312. PubMed ID: 39048164 [TBL] [Abstract][Full Text] [Related]
35. Transcriptome analysis revealed CENPF associated with glioma prognosis. Zhang M; Zhang Q; Bai J; Zhao Z; Zhang J Math Biosci Eng; 2021 Mar; 18(3):2077-2096. PubMed ID: 33892537 [TBL] [Abstract][Full Text] [Related]
36. Identification of latent biomarkers in connection with progression and prognosis in oral cancer by comprehensive bioinformatics analysis. Reyimu A; Chen Y; Song X; Zhou W; Dai J; Jiang F World J Surg Oncol; 2021 Aug; 19(1):240. PubMed ID: 34384424 [TBL] [Abstract][Full Text] [Related]
37. Integrated bioinformatics analysis for differentially expressed genes and signaling pathways identification in gastric cancer. Yang C; Gong A Int J Med Sci; 2021; 18(3):792-800. PubMed ID: 33437215 [No Abstract] [Full Text] [Related]
38. Identification of Differentially Expressed Genes (DEGs) Relevant to Prognosis of Ovarian Cancer by Use of Integrated Bioinformatics Analysis and Validation by Immunohistochemistry Assay. Zhang L; Sun L; Zhang B; Chen L Med Sci Monit; 2019 Dec; 25():9902-9912. PubMed ID: 31871312 [TBL] [Abstract][Full Text] [Related]
39. Identification of Novel Genes and Associated Drugs in Cervical Cancer by Bioinformatics Methods. Wang D; Liu Y; Cheng S; Liu G Med Sci Monit; 2022 Apr; 28():e934799. PubMed ID: 35428744 [TBL] [Abstract][Full Text] [Related]
40. Identification of Key Genes and Pathways in Myeloma side population cells by Bioinformatics Analysis. Yang Q; Li K; Li X; Liu J Int J Med Sci; 2020; 17(14):2063-2076. PubMed ID: 32922167 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]